secwatch.observer — SEC 8-K summary
======================================

Issuer:     PTC THERAPEUTICS, INC. (PTCT)
CIK:        0001070081
Form:       8-K
Filed at:   2026-03-25T23:59:59+00:00
Accession:  0001104659-26-034207
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PTC Therapeutics appoints biotech banking veteran Jessica Chutter to board
--------------------------------------------------------------------------

- Jessica Chutter appointed to board effective March 24, 2026, as Class I director.
- Chutter spent 40+ years at Morgan Stanley, most recently as Managing Director and Chair of Biotech Investment Banking.
- She was involved in ~$80B in capital raising and ~$85B in strategic transactions at Morgan Stanley.
- Initial director equity grant: 3,475 stock options (36-month monthly vest) and 4,000 RSUs (3-year annual vest).
- Also receives pro-rated annual grant: 2,896 stock options and 3,333 RSUs; eligible for future grants per board policy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1070081/000110465926034207/0001104659-26-034207-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1070081/000110465926034207/tmb-20260324x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-034207

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer